Llwytho...
Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features
Antineoplastic agents that utilize the immune system have revolutionized cancer treatment. Specifically, implementation of immune checkpoint inhibitors, monoclonal antibodies that block cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), programmed cell death protein 1 (PD-1), or programmed death...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Am Acad Dermatol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492441/ https://ncbi.nlm.nih.gov/pubmed/32360716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2020.04.105 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|